657 related articles for article (PubMed ID: 30497118)
41. Feasibility of the Engager™ aortic transcatheter valve system using a flexible over-the-wire design.
Sündermann SH; Grünenfelder J; Corti R; Rastan AJ; Linke A; Lange R; Falk V; Bleiziffer S
Eur J Cardiothorac Surg; 2012 Oct; 42(4):e48-52. PubMed ID: 22743081
[TBL] [Abstract][Full Text] [Related]
42. Impact of preoperative moderate/severe mitral regurgitation on 2-year outcome after transcatheter and surgical aortic valve replacement: insight from the Placement of Aortic Transcatheter Valve (PARTNER) Trial Cohort A.
Barbanti M; Webb JG; Hahn RT; Feldman T; Boone RH; Smith CR; Kodali S; Zajarias A; Thompson CR; Green P; Babaliaros V; Makkar RR; Szeto WY; Douglas PS; McAndrew T; Hueter I; Miller DC; Leon MB;
Circulation; 2013 Dec; 128(25):2776-84. PubMed ID: 24152861
[TBL] [Abstract][Full Text] [Related]
43. Transapical transcatheter aortic valve for severe aortic regurgitation: expanding the limits.
Wendt D; Kahlert P; Pasa S; El-Chilali K; Al-Rashid F; Tsagakis K; Dohle DS; Erbel R; Jakob H; Thielmann M
JACC Cardiovasc Interv; 2014 Oct; 7(10):1159-67. PubMed ID: 25129668
[TBL] [Abstract][Full Text] [Related]
44. Early Outcomes for Valve-in-valve Transcatheter Aortic Valve Replacement in Degenerative Freestyle Bioprostheses.
Sang SLW; Beute T; Heiser J; Berkompas D; Fanning J; Merhi W
Semin Thorac Cardiovasc Surg; 2018 Autumn; 30(3):262-268. PubMed ID: 29158054
[TBL] [Abstract][Full Text] [Related]
45. Management of paravalvular regurgitation after Edwards SAPIEN transcatheter aortic valve replacement: management of paravalvular regurgitation after TAVR.
Martinez CA; Singh V; O'Neill BP; Alfonso CE; Bilsker MS; Martinez Clark P; Williams D; Cohen MG; Heldman AW; O'Neill WW
Catheter Cardiovasc Interv; 2013 Aug; 82(2):300-11. PubMed ID: 23580318
[TBL] [Abstract][Full Text] [Related]
46. Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients.
Ye J; Cheung A; Lichtenstein SV; Pasupati S; Carere RG; Thompson CR; Sinhal A; Webb JG
Eur J Cardiothorac Surg; 2007 Jan; 31(1):16-21. PubMed ID: 17126558
[TBL] [Abstract][Full Text] [Related]
47. 5-Year Outcomes of Self-Expanding Transcatheter Versus Surgical Aortic Valve Replacement in High-Risk Patients.
Gleason TG; Reardon MJ; Popma JJ; Deeb GM; Yakubov SJ; Lee JS; Kleiman NS; Chetcuti S; Hermiller JB; Heiser J; Merhi W; Zorn GL; Tadros P; Robinson N; Petrossian G; Hughes GC; Harrison JK; Conte JV; Mumtaz M; Oh JK; Huang J; Adams DH;
J Am Coll Cardiol; 2018 Dec; 72(22):2687-2696. PubMed ID: 30249462
[TBL] [Abstract][Full Text] [Related]
48. Modified implantation height of the Sapien3™ transcatheter heart valve.
Wendt D; Shehada SE; König L; Kahlert P; Frey U; Mourad F; Jakob H; Thielmann M; El Gabry M
Minim Invasive Ther Allied Technol; 2020 Apr; 29(2):70-77. PubMed ID: 31012785
[No Abstract] [Full Text] [Related]
49. Worldwide experience with the 29-mm Edwards SAPIEN XT™ transcatheter heart valve in patients with large aortic annulus.
Wendler O; Thielmann M; Schroefel H; Rastan A; Treede H; Wahlers T; Eichinger W; Walther T
Eur J Cardiothorac Surg; 2013 Feb; 43(2):371-7. PubMed ID: 22522982
[TBL] [Abstract][Full Text] [Related]
50. Outcome of paravalvular leak repair after transcatheter aortic valve replacement with a balloon-expandable prosthesis.
Dhoble A; Chakravarty T; Nakamura M; Abramowitz Y; Tank R; Mihara H; Mangat G; Jilaihawi H; Shiota T; Makkar R
Catheter Cardiovasc Interv; 2017 Feb; 89(3):462-468. PubMed ID: 27219874
[TBL] [Abstract][Full Text] [Related]
51. Predictors of Paravalvular Regurgitation After Implantation of the Fully Repositionable and Retrievable Lotus Transcatheter Aortic Valve (from the REPRISE II Trial Extended Cohort).
Blackman DJ; Meredith IT; Dumonteil N; Tchétché D; Hildick-Smith D; Spence MS; Walters DL; Harnek J; Worthley SG; Rioufol G; Lefèvre T; Houle VM; Allocco DJ; Dawkins KD
Am J Cardiol; 2017 Jul; 120(2):292-299. PubMed ID: 28535962
[TBL] [Abstract][Full Text] [Related]
52. [Preliminary clinical experience of the novel transcatheter aortic valve system Prizvalve
Wei JF; Yang HR; Peng Y; He S; Chen Y; Zhao ZG; Meng W; Zhou X; Liang YJ; Zhou WX; Wei X; Li X; Chen F; Zhu ZK; Zhang Y; He JJ; Chen M; Feng Y
Zhonghua Xin Xue Guan Bing Za Zhi; 2022 Feb; 50(2):137-141. PubMed ID: 35172457
[No Abstract] [Full Text] [Related]
53. Transcatheter aortic valve implantation: results of the current development and implantation of a new Brazilian prosthesis.
Gaia DF; Palma JH; Ferreira CB; Souza JA; Gimenes MV; Macedo MT; Martins MR; Buffolo E
Rev Bras Cir Cardiovasc; 2011; 26(3):338-47. PubMed ID: 22086569
[TBL] [Abstract][Full Text] [Related]
54. Beyond the short-term: clinical outcome and valve performance 2 years after transcatheter aortic valve implantation in 227 patients.
Bleiziffer S; Mazzitelli D; Opitz A; Hettich I; Ruge H; Piazza N; Lange R
J Thorac Cardiovasc Surg; 2012 Feb; 143(2):310-7. PubMed ID: 22137802
[TBL] [Abstract][Full Text] [Related]
55. Transcatheter Aortic Valve Implantation Versus Surgical Aortic Valve Replacement for Severe Aortic Stenosis in Patients With Chronic Kidney Disease Stages 3b to 5.
D'Errigo P; Moretti C; D'Ascenzo F; Rosato S; Biancari F; Barbanti M; Santini F; Ranucci M; Miceli A; Tamburino C; Onorati F; Santoro G; Grossi C; Fusco D; Seccareccia F;
Ann Thorac Surg; 2016 Aug; 102(2):540-7. PubMed ID: 27130249
[TBL] [Abstract][Full Text] [Related]
56. A versatile transapical device for aortic valvular disease: One-year outcomes of a multicenter study on the J-Valve system.
Tung M; Wang X; Li F; Wang H; Guo Y; Wang C; Wei L; Luo X; Wang X; Wang W
J Cardiol; 2018 Nov; 72(5):377-384. PubMed ID: 30064947
[TBL] [Abstract][Full Text] [Related]
57. Transcatheter aortic valve implantation: first results from a multi-centre real-world registry.
Zahn R; Gerckens U; Grube E; Linke A; Sievert H; Eggebrecht H; Hambrecht R; Sack S; Hauptmann KE; Richardt G; Figulla HR; Senges J;
Eur Heart J; 2011 Jan; 32(2):198-204. PubMed ID: 20864486
[TBL] [Abstract][Full Text] [Related]
58. Transapical transcatheter aortic valve implantation: follow-up to 3 years.
Ye J; Cheung A; Lichtenstein SV; Nietlispach F; Albugami S; Masson JB; Thompson CR; Munt B; Moss R; Carere RG; Jamieson WR; Webb JG
J Thorac Cardiovasc Surg; 2010 May; 139(5):1107-13, 1113.e1. PubMed ID: 20412948
[TBL] [Abstract][Full Text] [Related]
59. 3-Year Outcomes in High-Risk Patients Who Underwent Surgical or Transcatheter Aortic Valve Replacement.
Deeb GM; Reardon MJ; Chetcuti S; Patel HJ; Grossman PM; Yakubov SJ; Kleiman NS; Coselli JS; Gleason TG; Lee JS; Hermiller JB; Heiser J; Merhi W; Zorn GL; Tadros P; Robinson N; Petrossian G; Hughes GC; Harrison JK; Maini B; Mumtaz M; Conte J; Resar J; Aharonian V; Pfeffer T; Oh JK; Qiao H; Adams DH; Popma JJ;
J Am Coll Cardiol; 2016 Jun; 67(22):2565-74. PubMed ID: 27050187
[TBL] [Abstract][Full Text] [Related]
60. Transcatheter Aortic Valve Implantation for Treatment of Aortic Valve Stenosis: A Health Technology Assessment.
Health Quality Ontario
Ont Health Technol Assess Ser; 2016; 16(19):1-94. PubMed ID: 27990197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
